HB 754 requires gender clinics receiving state funding and insurance providers covering gender transition procedures to also offer and cover detransition services (medical or mental health care to reverse or manage effects of transition). It applies specifically to state-funded clinics and insurers, mandating they report detailed statistics on gender transition procedures to the Tennessee Department of Health. The reporting includes patient demographics, procedure types, medications, and diagnoses - while excluding personally identifiable health information. Data must be submitted monthly and compiled into an annual public report starting in 2025. The bill does not restrict access to gender transition care but adds transparency and service parity requirements.
HB 179 modifies Tennessee's criminal abortion law by adding exceptions that exempt certain abortions from criminal prosecution. It specifies that performing an abortion is not a crime if it is necessary to protect the pregnant person's physical or mental health, or if the pregnancy resulted from rape or incest (as defined in Tennessee law). The bill amends Title 39, Chapter 15 of Tennessee Code, reclassifying such abortions as non-criminal under these specific circumstances. This change takes effect July 1, 2025, directly affecting licensed physicians performing abortions and pregnant individuals in these defined situations.
SB 440 clarifies that standalone dental and vision insurance plans (known as "excepted benefits") are not required to cover specific medical treatments, services, or conditions unless state law explicitly mandates it. This change directly affects health insurance plans offering these stand-alone benefits, removing an implied obligation to cover certain medical needs under those plans. The law applies to all new or renewed insurance policies issued on or after July 1, 2025, ensuring clarity for insurers and policyholders. It does not alter existing coverage requirements for standard health insurance plans.
SB 449, the "Fertility Treatment and Contraceptive Protection Act," establishes legal rights for individuals in Tennessee to access fertility treatments and contraception without state prohibition. It defines "fertility treatment" broadly to include procedures like in vitro fertilization, genetic testing of embryos, and medication for fertility, while defining "contraception" to cover methods such as birth control pills, emergency contraceptives, and sterilization. The law explicitly states that Tennessee law does not prohibit these activities, overriding conflicting state laws. This act takes effect on July 1, 2025, directly affecting all residents seeking these health services within the state.
HB 1198 requires Tennessee health insurers and TennCare to allow patients to try biosimilar drugs (cost-effective copies of brand-name medications) before covering the original branded drug. It amends state law to permit health carriers to mandate a biosimilar trial for equivalent branded prescriptions, removing prior requirements for generic drug trials. The bill also directs TennCare’s pharmacy committee to consider biosimilar drugs when recommending medications for the state’s preferred drug list. These changes aim to reduce prescription drug costs by increasing biosimilar adoption, as stated in the bill’s legislative findings.
HB 1074 removes two notification requirements related to prior authorization for healthcare services in Tennessee. It eliminates the obligation for healthcare providers to inform patients when communicating with insurers about missing information for prior authorization requests, and it removes the requirement for utilization review organizations to notify patients when providers fail to submit needed information within seven days. The bill directly affects patients, healthcare providers, and insurance entities by changing communication protocols during the prior authorization process. These changes amend Tennessee Code Sections 63-1-171(b) and 56-6-705(a), effective upon becoming law (Public Chapter 125, enacted April 8, 2025).
SB 1063 removes two notification requirements related to prior authorization for healthcare services in Tennessee. It eliminates the requirement for healthcare providers to notify patients when communicating with insurance companies about missing information for prior authorization, and it removes the requirement for insurance companies to notify patients when additional information is needed from the patient or provider. The bill directly affects healthcare providers, insurance companies, and patients by reducing administrative steps in the prior authorization process. These changes amend Tennessee Code sections 63-1-171 and 56-6-705, effective April 3, 2025.
SB 577 amends Tennessee's TennCare program by shortening the time frame for implementing the annual coverage assessment from seven days to five days. It also establishes limits on hospital payments under specific circumstances, directly affecting TennCare administrators and participating hospitals. The bill changes the timing requirement in Tennessee Code Annotated Section 71-5-2005(d)(2)(D) and became effective April 3, 2025, after being signed by the Governor.
HB 584 extends the expiration date of Tennessee's annual limit on new nursing home beds from June 30, 2025, to June 30, 2029. The bill maintains the current cap of 125 new nursing home beds per fiscal year that the Health Facilities Commission can approve through its certificate of need process. This change directly affects nursing home operators seeking to expand their facilities and the commission responsible for reviewing such requests. The bill does not alter the 125-bed limit but only extends the period during which it remains in effect.
HB 395, the "Tennessee Genomic Security and End Organ Harvesting Act," prohibits Tennessee health insurers from covering organ transplants or post-transplant care if the organ was sourced from China or procured through sale/donation originating in China. It also bans medical and research facilities from using genetic sequencing equipment or software produced by entities linked to "foreign adversaries" (specifically targeting China per the bill's context), requiring replacement within 180 days. Additionally, the bill mandates that all genetic sequencing data must be stored within the United States, with remote access from outside the country prohibited without approval from the state health commissioner. The law takes effect on January 1, 2026, directly affecting health insurers, hospitals, and research facilities operating in Tennessee.
